Results 141 to 150 of about 7,224 (167)

Doxorubicin/tenofovir-alafenamide

Reactions Weekly, 2022
openaire   +1 more source

Tenofovir Alafenamide

Annals of Pharmacotherapy, 2016

exaly  

Tenofovir Alafenamide Fumarate Therapy for HIV Treatment: Cardiometabolic and Renal Safety

AIDS Research and Human Retroviruses, 2020
Gregory Trypsianis, Nikolaos Papanas, Vasilis Petrakis   +2 more
exaly  

Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting

AIDS Patient Care and STDs, 2019
Pia Kivelä, Jussi Sutinen
exaly  

Bictegravir/emtricitabine/tenofovir-alafenamide

Reactions Weekly, 2023
openaire   +2 more sources

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Lancet, The, 2015
Daniel Podzamczer, Paul Edward Sax, Scott Mccallister   +2 more
exaly  

Superior Efficacy and Improved Renal and Bone Safety After Switching from a Tenofovir Disoproxil Fumarate- to a Tenofovir Alafenamide-Based Regimen Through 96 Weeks of Treatment

AIDS Research and Human Retroviruses, 2018
Nicolas Margot, Scott Mccallister, Anthony Mills   +2 more
exaly  

TENOFOVIR ALAFENAMIDE HEMIFUMARATE

2013
LIU DAZHAN, SHI BING, WANG FANG, YU RICHARD HUNG CHIU   +3 more
openaire   +9 more sources

Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV

Pharmaceutics, 2019
Meredith Clark, Ashana Puri, Sonalika Bhattaccharjee   +2 more
exaly  

Tenofovir alafenamide for the treatment of chronic hepatitis B virus infection

Expert Review of Clinical Pharmacology, 2017
Robert Gish, John Ryan
exaly